Speaker: Massimo D’Amato, MD, Senior Investigator, Clinical Pharmacology, Rotta Research Laboratories, Monza, Italy The cholecystokinin (CCK) receptor antagonist dexloxiglu-mide (Rotta Research Laboratories/Forest Laboratories) might be a novel therapeutic agent for the treatment of constipation-predominant irritable bowel syndrome (C-IBS) in female patients, having demonstrated its effectiveness in relieving IBS symptoms, and because it is well-tolerated.

Continue reading " American College of Gastroenterology: CCK Receptor Antagonist for Constipation-Dominant IBS "

Novel Proton Pump Inhibitor for GERD with EE Speaker: Donald O. Castell, MD, Professor of Medicine, Medical University of South Carolina, Charleston, South Carolina Esomeprazole (Nexium generic, AstraZeneca), the S-isomer of generic omeprazole, when taken in doses of 40 mg daily, is more effective in rapidly achieving sustained resolution of daily and nocturnal heartburn in [...]

Continue reading " American College of Gastroenterology "